{
  "name": "Fluvoxamine",
  "genericName": "fluvoxamine",
  "brandNames": ["Luvox", "Luvox CR"],
  "tags": ["SSRI", "Antidepressant"],
  "dosing": {
    "adult_acute": "50 mg at bedtime, increase by 50 mg every 4-7 days",
    "adult_maintenance": "100-300 mg/day (OCD); 100-250 mg/day (MDD)",
    "notes": "Divide doses >100 mg/day (BID); CR formulation allows once-daily dosing; take at bedtime to minimize daytime sedation",
    "canadian_clinical": {
      "starting_dose": "50 mg at bedtime",
      "titration_schedule": "Increase by 50 mg every 4-7 days; divide BID when >100 mg/day",
      "max_dose_evidence": "300 mg/day",
      "max_dose_practice": "300 mg/day; rarely used at max dose due to sedation and GI effects",
      "inpatient_strategy": "Start 50 mg qHS; increase to 150-200 mg within 2 weeks as tolerated",
      "outpatient_strategy": "Start 50 mg qHS; slow titration; monitor for sedation and nausea"
    }
  },
  "warnings": [
    "Black box warning: Increased suicidal thinking in children/adolescents/young adults",
    "Strong CYP1A2 and CYP2C19 inhibitor - MULTIPLE significant drug interactions (clozapine, olanzapine, theophylline, warfarin)",
    "More sedating than other SSRIs - bedtime dosing preferred",
    "Higher GI side effects (nausea) than other SSRIs",
    "Less commonly prescribed due to drug interactions and side effect profile"
  ],
  "cautions": {
    "renal": "No specific adjustment, use caution",
    "hepatic": "Start with lower dose, titrate slowly in hepatic impairment",
    "pregnancy": "Pregnancy Category C; limited data available"
  },
  "citations": ["APA OCD Guidelines", "CANMAT Guidelines", "Luvox FDA Label"]
}
